First LIVE Coronavirus sample tested successfully with OTSAW UV-C LED disinfection robot

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SINGAPORE, Aug. 25, 2020 /PRNewswire/ — OTSAW has built the world’s first successfully laboratory tested human Coronavirus exterminating machine using OTSAW’s patented UV-C LED, the O-RX. Its efficacy has been lab tested using high concentrations of live samples of human Coronavirus flown from the United States with results just released.

OTSAW LogoOTSAW Logo

 

Based on results and tests carried out by A*STAR completed on August 21st, a 99.9% efficacy for disinfection was achieved within 5 minutes, for the OTSAW O-RX at a working distance of 2.5m, outperforming specifications of its disinfectant rivals that have not been laboratory tested.

The OTSAW O-RX from concept, design, development and production is made by the team in Singapore. Its battery lasts five hours, and LED lamps make it environmentally friendly. It can disinfect 4000sqft (371.6sqm) hourly.

OTSAW are confident to lead the charge in disinfectant technology. Robot compliance can be based on prediction. It is a necessity when purchasing disinfection service robots, to obtain genuine laboratory results. Findings have given them a whole new certainty in making an impact in the world to help at this difficult moment.

It was a practical and challenging decision to obtain live virus samples, as the samples were prioritised for vaccine development. Amongst OTSAW there is a company ethos that science-based testing is the only way to ensure efficacy and effectiveness against the Coronavirus for the OTSAW O-RX Disinfectant robot.

CEO/Founder of OTSAW Ling Ting Ming said, “The world has gone through drastic changes and is delicately poised socially and economically for changes ahead. OTSAW and the O-RX are now part of this new world as we restart and focus to unite humanity and beat this virus.”

OTSAW is a global pioneer in advanced robotics technologies and next-generation artificial intelligence for healthcare, security delivery and mobility applications to improve safety, business processes and everyday lives.  For additional information, please visit http://www.otsaw.com.

For media queries, please contact Cecilia Yap at PR@otsaw.com, +65 9380 4067.

View original content to download multimedia:http://www.prnewswire.com/news-releases/first-live-coronavirus-sample-tested-successfully-with-otsaw-uv-c-led-disinfection-robot-301117519.html

SOURCE OTSAW

Staff

Recent Posts

CTG Appoints Dan Stoke Vice President of U.S. Healthcare Business

Growth-Oriented Healthcare IT Leader to Build on CTG’s Strong Industry Legacy; Drive Growth, Innovation, and…

2 hours ago

TruBridge Announces Participation in the KeyBanc Capital Markets Healthcare Forum

MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced that management will participate…

2 hours ago

WTWH Healthcare, a WTWH Media Company, Announces 2025 Aspect Awards Winners

CLEVELAND, March 14, 2025 /PRNewswire/ -- WTWH Healthcare, a WTWH Media company, is proud to…

5 hours ago

FLORIDA SOUTHERN COLLEGE NAMES BRITTANY BEHRENS, MSN, RN, CNE, CHSE, THE MAIDA BADCOCK POU ENDOWED CHAIR IN NURSING SIMULATION

LAKELAND, Fla., March 14, 2025 /PRNewswire/ -- Florida Southern College is excited to announce Brittany Behrens,…

5 hours ago

BioSurfaces and Morphocell Technologies Announce Collaboration to Explore Therapeutic Applications of Bio-Spun™ Material

ASHLAND, Mass., March 14, 2025 /PRNewswire/ -- BioSurfaces, a leader in advanced nanofiber materials, and…

5 hours ago

Biolexis Therapeutics Unlocks a New Frontier in GLP-1 Receptor Activation

CryoEM Confirms a First-in-Class Allosteric Binding Mode, Validating MolecuLern™ AI-Driven Discovery LEHI, Utah, March 14, 2025…

5 hours ago